Back to search

Denmark· DK-28103267301

Mixtard 30 Penfill

A insulin (human) product containing insulin, humant (rdna), isophan(nhp)insulin, humant (rdna), registered in Denmark by Novo Nordisk A/S. The same ATC class is registered in 9 of our 19 countries.

ATC A10AD01

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedMixtard 30 PenfillATCA10AD01REGISTER NO.DK-28103267301PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Insulin (human) is registered in 9 of 19 countries.

Countries holding a registration under ATC A10AD01 (insulin (human)), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 5 of them publish a price we can compare per daily dose

Insulin (human) · ATC A10AD01

9 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
Insulin, humant (rDNA), Isophan(NHP)insulin, humant (rDNA)
Manufacturer
Novo Nordisk A/S
Country
Denmark (DK)
ATC code
A10AD01
ATC class
Insulin (human)
Defined daily dose
40 E, P
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28103267301

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

461 interactions on record for insulin (human).

Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Insulin (human) · interactions on record

461 records

  • 15 severe
  • 395 moderate
  • 50 minor

Most severe, free to view

  • SucralfateA02BX02moderate
  • ThiethylperazinA04AB03moderate
  • TriflupromazinA04AD06moderate
  • PrednisoloneA07EA01moderate

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fff3a5ec-8526-4cfe-9ad2-cdea16a1de2b
GET /v1/drugs/fff3a5ec-8526-4cfe-9ad2-cdea16a1de2b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "injektionsvæske, suspension, cylinderampul",
  "source": "dkma",
  "strength": "100 IE/ml",
  "auth_role": "RAP",
  "dk_drugid": "28103267301",
  "substance": "Insulin, humant (rDNA), Isophan(NHP)insulin, humant (rDNA)",
  "auth_procedure": "Central",
  "in_medicinpriser": false,
  "registration_date_serial": "37536"
}

See everything about insulin (human).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.